Mycoplasmosis In Goats: Prevention, Diagnosis, Treatment
Comprehensive guide to understanding, preventing, and managing mycoplasma infections in goat herds for optimal health and productivity.
Mycoplasmosis represents one of the most challenging infectious diseases affecting goats worldwide, primarily targeting the musculoskeletal, respiratory, and reproductive systems. Caused by various Mycoplasma species, this condition leads to debilitating lameness, severe pneumonia, mastitis, and even sudden deaths, resulting in significant economic losses for goat farmers. Early recognition and intervention are crucial to mitigate its spread and impact on herd productivity.
Understanding the Pathogens Behind the Disease
The primary culprits are bacteria from the Mycoplasma genus, notably Mycoplasma capricolum subsp. capripneumoniae (Mccp), responsible for contagious caprine pleuropneumonia (CCPP), as well as Mycoplasma mycoides subsp. mycoides (large colony type), Mycoplasma mycoides subsp. capri, and others like Mycoplasma ovipneumoniae. These organisms lack a cell wall, making them resistant to certain antibiotics like penicillin and allowing them to evade the host’s immune defenses effectively.
In goats, Mccp specifically causes acute pleuropneumonia, while other strains provoke polyarthritis and systemic infections. Transmission occurs mainly through respiratory droplets from coughing or sneezing infected animals, but can also happen via contaminated milk from dams with mastitis or direct contact during close herding. Overcrowding, poor ventilation, and stress factors exacerbate outbreaks.
Clinical Manifestations Across Age Groups
Symptoms vary by age, affected system, and strain virulence. In kids, infections often present as severe septicemia or arthritis, with hot, swollen joints leading to pronounced lameness, fever, weight loss, and a rough coat. Respiratory involvement may be subtle or absent initially.
Adult goats typically show a triad of mastitis, polyarthritis, and pneumonia. Does suffer agalactia (loss of milk production), painful udders, and lameness from joint inflammation. Respiratory signs include cough, rapid breathing (tachypnea), nasal discharge, anorexia, and high fever (up to 41.5°C or 106.7°F). Exercise intolerance progresses to open-mouth breathing and frothy saliva in advanced cases.
- Respiratory form (CCPP): Anorexia, dyspnea, polypnea, severe pleural effusion on necropsy.
- Arthritis: Multiple swollen joints, reluctance to move, dehydration.
- Mastitis: Udder swelling, reduced milk yield, potential abortion links.
- Septicemic form: Sudden weakness, high fever, rapid death without overt respiratory distress.
Neurologic signs like meningitis or sudden deaths occur less frequently but signal systemic spread. Hematologic changes include leukocytosis or leukopenia, thrombocytopenia, and hypoalbuminemia, reflecting inflammation and sepsis.
Diagnostic Approaches for Accurate Identification
Diagnosis combines clinical evaluation, laboratory tests, and postmortem findings. Veterinarians observe herd history, clinical signs, and perform joint fluid aspiration revealing increased white blood cells and Mycoplasma on culture or PCR.
Key diagnostics include:
| Method | Description | Advantages |
|---|---|---|
| PCR Testing | Detects Mycoplasma DNA in nasal swabs, joint fluid, or lung tissue. | Highly specific and sensitive; rapid results. |
| Culture | Grows organisms on special media from exudates. | Allows antibiotic sensitivity testing. |
| Serology | ELISA for antibodies. | Detects exposure in herds. |
| Necropsy | Straw-colored pleural fluid, fibrinous pneumonia, joint lesions. | Confirms cause in fatalities. |
Radiography may show lung consolidation, while bloodwork indicates sepsis markers. Differential diagnoses include viral pneumonias, pasteurellosis, or nutritional lameness.
Treatment Strategies: Antibiotics and Supportive Care
Treatment success hinges on early, aggressive intervention, though complete bacterial elimination is challenging due to persistence in carriers. Extralabel antibiotics are standard, requiring veterinary oversight per regulations like AMDUCA.
Effective options include:
- Macrolides: Tylosin (10 mg/kg IM q24h for 3 days) for CCPP.
- Tetracyclines: Long-acting oxytetracycline (20 mg/kg IM once).
- Fluoroquinolones: Enrofloxacin (5 mg/kg SC or intranasal), though relapse common after 30+ days.
- Florfenicol: Broad-spectrum for early pneumonia.
Avoid beta-lactams like penicillin, as Mycoplasma lack cell walls. Supportive measures: Isolate cases, provide fluids, NSAIDs for pain, and nutritious feed. Milk from treated does must be discarded or pasteurized. Prognosis varies; arthritis cases may recover partially, but chronic carriers persist.
Studies show temporary prevalence reduction with enrofloxacin in sheep (similar to goats), but rebound occurs, emphasizing test-and-slaughter in high-risk scenarios.
Prevention and Control Measures for Herds
Prevention focuses on biosecurity, as vaccines exist only in select countries with variable efficacy. Core strategies:
- Quarantine new arrivals: 30-60 days with PCR testing.
- Avoid overcrowding: Ensure ventilation, reduce stress.
- Culling policy: Remove clinically affected animals promptly.
- Hygiene: Disinfect housing, control ear mites (potential vectors).
- Herd monitoring: Routine nasal swabs for early detection.
In endemic areas, all-in-all-out management and separate kid rearing minimize dam-to-offspring transmission. USDA recommends biosecurity to curb M. ovipneumoniae spread to wildlife.
Impact on Goat Farming and Economic Considerations
Mycoplasmosis slashes productivity via milk loss, culls, and treatment costs. Outbreaks can decimate 20-50% of herds in severe CCPP cases. Farmers must balance treatment expenses against culling, often favoring depopulation in valuable genetics scenarios. Long-term, investing in closed herds and testing yields sustainable returns.
Global trade restrictions on infected regions underscore its notifiable status under WOAH.
FAQs on Mycoplasmosis in Goats
Q: Can mycoplasmosis be cured completely?
A: Clinical signs often resolve with antibiotics, but carriers may persist, necessitating ongoing management.
Q: Is vaccination available for goats?
A: Yes, in some countries for CCPP, providing good protection; consult local vets.
Q: How does it spread between goats?
A: Primarily airborne via respiratory secretions; also milk and possibly fomites.
Q: What are early warning signs in kids?
A: Lameness, swollen joints, fever, and lethargy.
Q: Are antibiotics like penicillin effective?
A: No, due to absent cell walls; use macrolides or tetracyclines instead.
Emerging Research and Future Directions
Ongoing studies explore strain variations and resistance patterns. Intranasal therapies show promise for reducing shedding, while genomic sequencing aids outbreak tracing. Integrated approaches combining antimicrobials, probiotics, and improved nutrition may enhance outcomes. Farmers should stay updated via extension services.
References
- Mycoplasma Pneumonia – Goats — Goats Extension. Accessed 2026. https://goats.extension.org/mycoplasma-pneumonia/
- Mycoplasma Pneumonias in Goats – Respiratory System — Merck Veterinary Manual. Accessed 2026. https://www.merckvetmanual.com/respiratory-system/respiratory-diseases-of-sheep-and-goats/mycoplasma-pneumonias-in-goats
- Antibiotic treatment of Mycoplasma ovipneumoniae in domestic sheep — PMC (NCBI). 2023-11-01. https://pmc.ncbi.nlm.nih.gov/articles/PMC10637703/
- Mycoplasmosis in Goats – Musculoskeletal System — Merck Veterinary Manual. Accessed 2026. https://www.merckvetmanual.com/musculoskeletal-system/lameness-in-goats/mycoplasmosis-in-goats
- Contagious caprine pleuropneumonia — World Organisation for Animal Health (WOAH). Accessed 2026. https://www.woah.org/en/disease/contagious-caprine-pleuropneumonia/
- Disease Alert: Mycoplasma Ovipneumoniae — USDA APHIS. Accessed 2026. https://www.aphis.usda.gov/livestock-poultry-disease/sheep-goat/mycoplasma-ovipneumoniae
Similar Articles
Read full bio of Sneha Tete
